Order Article Reprints

Nannini S, Guisier F, Curcio H, Ricordel C, Demontrond P, Abdallahoui S, Baloglu S, Greillier L, Chouaid C, Schott R. Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort. Current Oncology. 2024; 31(3):1656-1666. https://doi.org/10.3390/curroncol31030126

Nannini, Simon, Florian Guisier, Hubert Curcio, Charles Ricordel, Pierre Demontrond, Safa Abdallahoui, Seyyid Baloglu, Laurent Greillier, Christos Chouaid, and Roland Schott. 2024. "Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort" Current Oncology 31, no. 3: 1656-1666. https://doi.org/10.3390/curroncol31030126

Nannini, S., Guisier, F., Curcio, H., Ricordel, C., Demontrond, P., Abdallahoui, S., Baloglu, S., Greillier, L., Chouaid, C., & Schott, R. (2024). Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort. Current Oncology, 31(3), 1656-1666. https://doi.org/10.3390/curroncol31030126